1 / 8

HPV Vaccine Policy Project

HPV Vaccine Policy Project. CPCRN HPV Workgroup 2008 CPCRN National Meeting Miriam Laugesen, Ritesh Mistry, Roshan Bastani, Vicky Taylor, Jack Needleman and other interested CPCRNs. Background. HPV vaccine is a breakthrough, but there has been much controversy

whitby
Télécharger la présentation

HPV Vaccine Policy Project

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. HPV Vaccine Policy Project CPCRN HPV Workgroup 2008 CPCRN National Meeting Miriam Laugesen, Ritesh Mistry, Roshan Bastani, Vicky Taylor, Jack Needleman and other interested CPCRNs

  2. Background • HPV vaccine is a breakthrough, but there has been much controversy • Mandating vaccines: school entry, immigration • Concerns in public health community about competing costs and impact on Pap test usage • A consensus has yet to be reached about whether and how to promote the vaccine • State and national policy can have important impacts on vaccine awareness and vaccine usage

  3. HPV Policy Project Update • First paper: • Describes quantity and variety of HPV vaccine bills across 50 states from Jan 2006 – June 2008 • Traces the introduction, enactment, and failure to enactment of HPV vaccine bills • Data have been abstracted from all bills introduced over this time period • A complete draft of the paper has been written: • Submit to Health Affairs by end of December 2008 • Laugesen M, Mistry R, Carameli K, Needleman J, Bastani R.

  4. No activity: Alaska, Arkansas, Deleware Idaho, Nebraska, New Hampshire, Wyoming

  5. Enacted Bills (n=24, 26%)

  6. Examples of Next Papers • State level predictors of policy introduction and enactment • Case study of states: • comparing mandates, no mandates • A lot of activity, no activity • Impact of policies on outcomes such as knowledge / awareness, intention, uptake

  7. State-Level Predictors of Policy Activity • Outcomes: • Types of HPV vaccine bills introduced • Types of HPV vaccine bills enacted • State-level Predictors: • Population Size • SES: per capita income • Percent Democrats in upper and lower house • Party of governor • Conservativeness: percent Christian adherents, Death penalty state • HMO penetration • Cervical cancer burden

More Related